6943

543399

TARSONS

img img img img
No Data Available

TARSONS PRODUCTS LIMITED Share Price Update

As of the latest trading session, TARSONS PRODUCTS LIMITED is trading at ₹202.91, down by ₹-4.03 or -1.94% from its previous close. The stock has moved between ₹198.24 and ₹206.95 today. Over the past year, the stock has delivered a return of -47.91%. In the last month, it has returned -0.99%.

TARSONS PRODUCTS LIMITED performance

Today’s low Today’s high
₹ 198.24 ₹ 206.95
₹ 202.38
52 week low 52 week high
₹ 164.45 ₹ 458.00
₹ 202.38
Open Price ₹ 206.95
Prev. Close ₹ 206.95
Volume (Shares) 38636.00
Total traded value ₹ 78.19
Upper Circuit ₹ 248.34
Lower Circuit ₹ 165.56
info

Investment Returns

Over 1 Month -0.99% Over 3 Months 4.49% Over 6 Months -10.41% Over 1 Year -47.91%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

TARSONS PRODUCTS LIMITED fundamentals


  • Market cap (Cr) 1,072.20
  • P/E Ratio (TTM) 33.53
  • Beta 1.04
  • Book Value / share 124.48
  • Return on equity 6.71%
  • EPS (TTM) 6.38
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 7.09
info icon alternate text
  • Market cap (Cr) 1,070.80
  • P/E Ratio (TTM) 33.53
  • Beta 0.98
  • Book Value / share 124.48
  • Return on equity 6.71%
  • EPS (TTM) 6.38
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 7.09
info icon alternate text

TARSONS PRODUCTS LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 83.99
Operating Expense 82.82
Net Profit 7.09
Net Profit Margin (%) 8.44
Earnings Per Share (EPS) 1.33
EBITDA 37.50
Effective Tax Rate (%) 25.60
Particulars SEP 2025 (Values in Cr)
Revenue 80.51
Operating Expense 78.94
Net Profit 6.53
Net Profit Margin (%) 8.11
Earnings Per Share (EPS) 1.23
EBITDA 33.46
Effective Tax Rate (%) 26.46
Particulars JUN 2025 (Values in Cr)
Revenue 71.28
Operating Expense 71.08
Net Profit 3.57
Net Profit Margin (%) 5.00
Earnings Per Share (EPS) 0.67
EBITDA 26.81
Effective Tax Rate (%) 25.31
Particulars MAR 2025 (Values in Cr)
Revenue 93.04
Operating Expense 78.08
Net Profit 15.73
Net Profit Margin (%) 16.90
Earnings Per Share (EPS) 2.96
EBITDA 43.34
Effective Tax Rate (%) 26.28
Particulars DEC 2024 (Values in Cr)
Revenue 76.16
Operating Expense 67.99
Net Profit 7.61
Net Profit Margin (%) 9.99
Earnings Per Share (EPS) 1.43
EBITDA 30.04
Effective Tax Rate (%) 26.11
Particulars MAR 2025 (Values in Cr)
Revenue 314.18
Operating Expense 280.31
Net Profit 42.73
Net Profit Margin (%) 13.60
Earnings Per Share (EPS) 8.03
EBITDA 129.40
Effective Tax Rate (%) 26.16
Particulars MAR 2024 (Values in Cr)
Revenue 277.31
Operating Expense 222.10
Net Profit 51.25
Net Profit Margin (%) 18.48
Earnings Per Share (EPS) 9.63
EBITDA 117.60
Effective Tax Rate (%) 26.12
Particulars MAR 2023 (Values in Cr)
Revenue 283.25
Operating Expense 186.47
Net Profit 80.71
Net Profit Margin (%) 28.49
Earnings Per Share (EPS) 15.17
EBITDA 141.70
Effective Tax Rate (%) 25.76
Particulars MAR 2022 (Values in Cr)
Revenue 300.79
Operating Expense 174.28
Net Profit 100.66
Net Profit Margin (%) 33.46
Earnings Per Share (EPS) 19.46
EBITDA 161.17
Effective Tax Rate (%) 25.43
Particulars MAR 2021 (Values in Cr)
Revenue 228.91
Operating Expense 141.85
Net Profit 68.87
Net Profit Margin (%) 30.08
Earnings Per Share (EPS) 13.43
EBITDA 108.81
Effective Tax Rate (%) 25.48
Particulars MAR 2025 (Values in Cr)
Book Value / Share 118.45
ROE % 4.79
ROCE % 6.67
Total Debt to Total Equity 0.49
EBITDA Margin 32.32
Particulars MAR 2024 (Values in Cr)
Book Value / Share 115.19
ROE % 6.96
ROCE % 7.82
Total Debt to Total Equity 0.44
EBITDA Margin 37.56
Particulars MAR 2022 (Values in Cr)
Book Value / Share 92.06
ROE % 27.42
ROCE % 34.88
Total Debt to Total Equity 0.08
EBITDA Margin 53.58
Particulars MAR 2021 (Values in Cr)
Book Value / Share 12725.94
ROE % 28.19
ROCE % 33.85
Total Debt to Total Equity 0.14
EBITDA Margin 47.54
Particulars MAR 2025 (Values in Cr)
Book Value / Share 122.62
ROE % 6.71
ROCE % 8.15
Total Debt to Total Equity 0.38
EBITDA Margin 41.19
Particulars MAR 2024 (Values in Cr)
Book Value / Share 116.61
ROE % 8.62
ROCE % 9.98
Total Debt to Total Equity 0.31
EBITDA Margin 42.41
Particulars MAR 2023 (Values in Cr)
Book Value / Share 107.00
ROE % 15.24
ROCE % 18.79
Total Debt to Total Equity 0.12
EBITDA Margin 50.03
Particulars MAR 2022 (Values in Cr)
Book Value / Share 92.06
ROE % 27.42
ROCE % 34.88
Total Debt to Total Equity 0.08
EBITDA Margin 53.58
Particulars MAR 2021 (Values in Cr)
Book Value / Share 12725.94
ROE % 31.17
ROCE % 36.87
Total Debt to Total Equity 0.16
EBITDA Margin 47.54
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 25.65
Total Assets 1080.04
Total Liabilities 1080.04
Total Equity 630.21
Share Outstanding 5
Price to Book Ratio 2.46
Return on Assets (%) 2.75
Return on Capital (%) 3.11
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 22.61
Total Assets 972.18
Total Liabilities 972.18
Total Equity 612.86
Share Outstanding 5
Price to Book Ratio 3.38
Return on Assets (%) 4.38
Return on Capital (%) 4.9
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 85.81
Total Assets 544.22
Total Liabilities 544.22
Total Equity 489.83
Share Outstanding 5
Price to Book Ratio 7.65
Return on Assets (%) 18.49
Return on Capital (%) 20.17
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.14
Total Assets 295.95
Total Liabilities 295.95
Total Equity 244.33
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 23.27
Return on Capital (%) 27.81
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 8.45
Total Assets 990.62
Total Liabilities 990.62
Total Equity 652.38
Share Outstanding 5
Price to Book Ratio 2.46
Return on Assets (%) 4.31
Return on Capital (%) 4.84
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 9.53
Total Assets 953.21
Total Liabilities 953.21
Total Equity 620.41
Share Outstanding 5
Price to Book Ratio 3.38
Return on Assets (%) 5.37
Return on Capital (%) 5.84
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 59.96
Total Assets 725.68
Total Liabilities 725.68
Total Equity 569.30
Share Outstanding 5
Price to Book Ratio 4.98
Return on Assets (%) 11.12
Return on Capital (%) 11.87
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 85.81
Total Assets 544.22
Total Liabilities 544.22
Total Equity 489.83
Share Outstanding 5
Price to Book Ratio 7.65
Return on Assets (%) 18.49
Return on Capital (%) 19.68
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.14
Total Assets 295.94
Total Liabilities 295.94
Total Equity 244.33
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 23.27
Return on Capital (%) 27.81
Particulars MAR 2025 (Values in Cr)
Net Income 44.80
Cash from Operations 130.08
Cash from Investing -145.48
Cash from Financing 38.94
Net change in Cash 7.70
Free Cash Flow 281.78
Particulars MAR 2024 (Values in Cr)
Net Income 60.76
Cash from Operations 121.10
Cash from Investing -284.95
Cash from Financing 135.62
Net change in Cash -46.62
Free Cash Flow 305.43
Particulars MAR 2022 (Values in Cr)
Net Income 134.98
Cash from Operations 116.84
Cash from Investing -137.94
Cash from Financing 129.57
Net change in Cash 75.09
Free Cash Flow 248.81
Particulars MAR 2021 (Values in Cr)
Net Income 92.43
Cash from Operations 92.22
Cash from Investing -63.91
Cash from Financing -27.22
Net change in Cash -22.97
Free Cash Flow 154.10
Particulars MAR 2025 (Values in Cr)
Net Income 57.87
Cash from Operations 126.38
Cash from Investing -51.92
Cash from Financing -53.95
Net change in Cash 3.90
Free Cash Flow 278.03
Particulars MAR 2024 (Values in Cr)
Net Income 69.37
Cash from Operations 123.13
Cash from Investing -296.45
Cash from Financing 136.40
Net change in Cash -55.01
Free Cash Flow 306.86
Particulars MAR 2023 (Values in Cr)
Net Income 108.72
Cash from Operations 99.90
Cash from Investing -178.54
Cash from Financing 84.56
Net change in Cash -18.38
Free Cash Flow 289.87
Particulars MAR 2022 (Values in Cr)
Net Income 134.98
Cash from Operations 116.84
Cash from Investing -137.94
Cash from Financing 129.57
Net change in Cash 75.11
Free Cash Flow 248.81
Particulars MAR 2021 (Values in Cr)
Net Income 92.43
Cash from Operations 92.22
Cash from Investing -63.91
Cash from Financing -27.22
Net change in Cash -22.97
Free Cash Flow 154.10
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8081.60 63.97 12.78 116201.01 6680.00 8249.95
FORTIS MALAR HOSPITALS LIMITED 54.06 22.34 2.94 101.32 40.75 81.00
SHREE PACETRONIX LTD. 136.00 20.51 3.00 51.00 66.10 283.15
TRANSGENE BIOTEK LTD. 3.20 0.00 2.63 24.25 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8081.60 80.01 12.47 116201.01 6680.00 8249.95
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 38.02 0.00 -11.04 28.40 30.30 57.48
KOVAI MEDICAL CENTER & HO 5463.50 25.35 5.02 5977.07 5010.00 6725.00

TARSONS PRODUCTS LIMITED shareholding pattern

Holding
51.63%
47.3%
0.87%
0.18%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

TARSONS PRODUCTS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
201.52 -2.62 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 214.00
  • 26 Days 211.80
  • 10 Days 216.00
  • 50 Days 207.90
  • 12 Days 215.90
  • 100 Days 215.80
  • 20 Days 213.70
  • 200 Days 248.80
215.25 PIVOT
First Support 211.34 First Resistance 217.73 Second Support 208.86 Second Resistance 221.64 Third Support 204.95 Third Resistance 224.12
RSI 46.45 ADX 66.97 MACD 4.12 Williams % R -93.39 Commodity Channel Index (CCI) -123.58
Date 2026-05-15 Week 31742.00 Same Day 25560.00 Month 52785.00
1 Year 1.04 3 Year 0.74
Over 1 Month
-0.99% down
Over 1 Year
-47.91% down
Over 3 Months
4.49% down
Over 3 Years
-27.68% down
Over 6 Months
-10.41% down
Over 5 Years
-24.04% down

TARSONS PRODUCTS LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
20 Sep 2024 2.0 Final 20 Sep 2024 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
20 Sep 2024 2.0 Final 20 Sep 2024 Equity shares

Top Gainers

Top Losers

TARSONS PRODUCTS LIMITED Share Price

Tarsons Products Limited was incorporated as Tarsons Products Private Limited on July 5, 1983. The Company was subsequently converted into a Public Limited Company and the name of the Company was changed to Tarsons Products Limited on June 14, 2021.

Tarsons is an Indian labware Company engaged in designing, developing, manufacturing and marketing of consumables', reusables' and others' (including benchtop equipment), used in various laboratories across research organizations, academia institutes, pharmaceutical companies, CROs, diagnostic companies and hospitals. The Company is also engaged in the manufacturing of wide range of quality labware products which helps scientific discovery and improve healthcare. Tarsons currently operate through five manufacturing facilities located in West Bengal. The Company cater to a diverse range of end customers across various sectors which include research organizations, academic institutions, pharmaceutical companies, CROs, diagnostic companies and hospitals and distribute the products to these end customers on a pan-India basis through authorized distributors. The Company has a subsidiary named Inlabro Pte. Ltd. established in Republic of Singapore.

The Company commenced production of pipette tips in 1984. It started production of Centrifuge tubes in 1987. In 2002, the Company pioneered the first fully robotic clean room plant for manufacturing molecular biology consumables. Later on, it set up manufacturing facility expanding into production of fully automatic centrifuge tubes, and cryogenic vials in Dhulagarh in 2012. It established line for PCR products at Jangalpur in 2019. The Company acquired land in Panchla and in Amta for developing and expanding its capacity in 2021-22.

In November 2021, the Company made an Initial Public Offering (IPO) of 15,465,861 Equity Shares of face value of Rs 2 each of the Company aggregating to Rs 1023.54 Crore, comprising of a Fresh Issue of 2,265,861 Equity Shares aggregating to Rs 149.70 Crore and an Offer for Sale of 13,200,000 Equity Shares aggregating to Rs 873.84 Crore. The allotted shares were listed on the BSE Ltd and National Stock Exchange of India(NSE) on 26 November, 2021.

On 20 December, 2023, the Company, through its wholly owned subsidiary, Tarsons Life Science Pte Ltd., acquired stake Nerbe R & D GmbH and Nerbe plus GmbH & Co. KG in Hamburg, Germany with complete ownership/ control with effect from 1st January, 2024.

The Company has completed the installation and validation of the radiation facility and fulfilment center in FY 2025.

Parent organization Indian Private
NSE symbol TARSONS
Founded 1983
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Tarsons Products Ltd?

Answer Field

Tarsons Products Ltd share price is for NSE ₹ 202.91 & for BSE ₹ 203.70 as on May 18 2026 02:15 PM.

What is the Market Cap of Tarsons Products Ltd Share?

Answer Field

The market cap of Tarsons Products Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 18 2026 02:15 PM.

What is the 52 Week High and Low of Tarsons Products Ltd?

Answer Field

The 52 Week High and Low of Tarsons Products Ltd for NSE is ₹ 458.00 and ₹ 164.45 and for BSE is ₹ 457.25 and ₹ 164.15.

What is 1 year return for Tarsons Products Ltd?

Answer Field

The 1 year returns on the stock has been -47.91%.

What is the P/E Ratio of Tarsons Products Ltd Share?

Answer Field

As on May 18 2026 02:15 PM the price-to-earnings (PE) ratio for Tarsons Products Ltd share is 33.53.

What is the PB ratio of Tarsons Products Ltd Share?

Answer Field

As on May 18 2026 02:15 PM, the price-to-book (PB) ratio for Tarsons Products Ltd share is 124.48.

How to Buy Tarsons Products Ltd Share?

Answer Field

You can trade in Tarsons Products Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Tarsons Products Ltd Share on Bajaj Broking App?

Answer Field

To buy Tarsons Products Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Tarsons Products Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|